Jublia is a prescription topical antifungal solution used to treat toenail fungus, known medically as onychomycosis. It contains the active ingredient efinaconazole at a 10% concentration and is applied directly to affected toenails once daily for 48 weeks. The FDA approved it specifically for toenail infections caused by the two most common fungal culprits: Trichophyton rubrum and Trichophyton mentagrophytes.
How Jublia Works
Toenail fungus thrives because fungal cells build protective membranes using a fatty substance called ergosterol. Jublia blocks a key step in ergosterol production, which weakens and destabilizes the fungal cell membrane. Without a functioning membrane, the fungal cells can’t survive or reproduce. This doesn’t kill the infection overnight, though. The solution works gradually as healthy nail grows in to replace the damaged, infected nail.
One advantage of Jublia over older topical treatments is its ability to penetrate through the nail plate to reach the fungus underneath. Toenail fungus is notoriously difficult to treat topically because the nail itself acts as a barrier, and many earlier products struggled to deliver enough active ingredient to the infection site.
How Effective Is Jublia?
In two large Phase 3 clinical trials, Jublia produced a complete cure (meaning the nail looked entirely normal and lab tests confirmed the fungus was gone) in about 15% to 18% of patients after 52 weeks. That may sound modest, but the placebo group saw complete cure rates of only 3% to 5.5%, so the medication made a meaningful difference. More encouraging is the mycological cure rate, which measures whether the fungus itself has been eliminated regardless of how the nail looks. Around 53% to 55% of Jublia users achieved mycological cure, compared to roughly 17% with placebo.
The gap between “fungus gone” and “nail looks normal” matters. Even after the infection clears, it takes additional months for a healthy toenail to fully grow out and replace the thickened, discolored nail. So a nail can still look rough even when the treatment has worked. Patience is genuinely part of the process here.
How Jublia Compares to Oral Treatments
Oral antifungal pills remain the most effective option for toenail fungus. Indirect comparisons (no head-to-head trials exist) suggest that standard oral antifungals produce higher mycological cure rates than Jublia. However, oral antifungals carry systemic side effects, including potential liver toxicity, and require blood monitoring during treatment. Some people can’t take them due to liver conditions, drug interactions, or other health concerns.
Jublia fills an important role for patients who want to avoid oral medication or aren’t good candidates for it. Compared to ciclopirox, an older topical nail lacquer, indirect analyses found no significant difference in effectiveness, though Jublia’s formulation is generally considered easier to use since it doesn’t require filing the nail before application.
How to Apply It
Jublia is applied once daily to the affected toenail for 48 weeks, which is close to a full year of treatment. The solution comes with a flow-through brush applicator. You apply it to the entire toenail surface, the underside of the nail tip, the skin around the nail, and the nail folds on either side. It’s approved for adults and children aged 6 and older.
Consistency is critical. Missing doses or stopping early significantly reduces the chance of clearing the infection. Because toenails grow slowly (roughly 1 to 2 millimeters per month), visible improvement typically takes several months of daily use. Many patients won’t see obvious changes in nail appearance until they’re well into the treatment course, which can be discouraging but is normal.
Side Effects
Jublia’s side effects are almost entirely limited to the application site, which is one of its main advantages as a topical treatment. Very little of the medication is absorbed into the bloodstream. In clinical trials involving over 1,200 patients treated for up to 48 weeks, the most common reactions were:
- Ingrown toenail: 2.3% of users
- Skin irritation around the nail (application site dermatitis): 2.2%
- Small blisters at the application site: 1.6%
- Pain at the application site: 1.1%
These rates are low, and the reactions are typically mild. There are no known serious systemic side effects, and the medication doesn’t require liver function testing or blood work during treatment, unlike oral antifungals.
Cost and Generic Availability
Jublia has been one of the more expensive topical antifungals on the market, and cost is a common barrier for patients. The FDA has approved generic versions of efinaconazole 10% from multiple manufacturers, with the first approval dating to December 2020. However, actual pharmacy availability of generics has been limited. If you’re considering Jublia, checking with your pharmacy and insurance plan about coverage and generic options is a practical first step, as out-of-pocket costs can vary widely.
Who Jublia Is Best Suited For
Jublia is most often prescribed for people with mild to moderate toenail fungus who prefer a topical treatment over pills, or who can’t tolerate oral antifungals due to liver concerns, medication interactions, or other health issues. It’s also a reasonable option for patients with fungal infection in just one or two nails rather than widespread involvement.
For severe infections where the fungus has spread to multiple nails or involves a large portion of the nail plate, oral treatment generally offers better results. In some cases, doctors combine topical and oral approaches. The right choice depends on how extensive the infection is, your overall health, and how you weigh the trade-off between higher cure rates and the possibility of systemic side effects.